Belladonna and Opium Suppository shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting Jul 23, 2026 · last update Jul 23, 2026
Manufacturers: Padagis US LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 23, 2026 Updated Jul 23, 2026 Discontinued Jul 23, 2026 |
| Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 23, 2026 Updated Jul 23, 2026 Discontinued Jul 23, 2026 |
| Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-04) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 23, 2026 Updated Jul 23, 2026 Discontinued Jul 23, 2026 |
| Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 23, 2026 Updated Jul 23, 2026 Discontinued Jul 23, 2026 |